55292-321-20 : NDC 2026 Code

55292-321-20 : Osilodrostat ( Isturisa )

Additionally :

You can get information about “55292-321-20” NDC code in 55292-321-20 in HTML format

HTML | 55292-321-20 in TXT (Plain Text) format

TXT | 55292-321-20 in PDF (Portable Document Format)

PDF | 55292-321-20 in XML format

XML formats.

NDC Code : 55292-321-20 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "55292-321-20",
    "PackageDescription": "20 TABLET, COATED in 1 BLISTER PACK (55292-321-20) ",
    "NDC11Code": "55292-0321-20",
    "ProductNDC": "55292-321",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Isturisa",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Osilodrostat",
    "DosageFormName": "TABLET, COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20200331",
    "EndMarketingDate": "20291231",
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA212801",
    "LabelerName": "Recordati Rare Diseases, Inc.",
    "SubstanceName": "OSILODROSTAT PHOSPHATE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cortisol Synthesis Inhibitor [EPC], Cytochrome P450 11B1 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20200331",
    "EndMarketingDatePackage": "20291231",
    "SamplePackage": "N"
  }
}